FGF15 Protects Septic Mice by Inhibiting Inflammation and Modulating Treg Responses

References

• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Merino I, de la Fuente A, Domínguez-Gil M, Eiros JM, Tedim AP, Bermejo-Martín JF. Digital PCR applications for the diagnosis and management of infection in critical care medicine. Crit Care. 2022;26(1):63. doi:10.1186/s13054-022-03948-8
   PubMed Web of Science ®Google Scholar
• Doran KS, Banerjee A, Disson O, Lecuit M. Concepts and mechanisms: crossing host barriers. Cold Spring Harb Perspect Med. 2013;3(7):a010090. doi:10.1101/cshperspect.a010090
   PubMed Web of Science ®Google Scholar
• Tamayo E, Fernández A, Almansa R, et al. Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur Cytokine Netw. 2011;22(2):82–87. doi:10.1684/ecn.2011.0281
   PubMed Web of Science ®Google Scholar
• Dinarello CA. How interleukin-1β induces gouty arthritis. Arthritis Rheum. 2010;62(11):3140–3144. doi:10.1002/art.27663
   PubMed Web of Science ®Google Scholar
• Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98–107. doi:10.1038/nri2925
   PubMed Web of Science ®Google Scholar
• Solovic I, Sester M, Gomez-Reino JJ, et al. The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J. 2010;36(5):1185–1206. doi:10.1183/09031936.00028510
   PubMed Web of Science ®Google Scholar
• Grau GE, Maennel DN. TNF inhibition and sepsis -- sounding a cautionary note. Nat Med. 1997;3(11):1193–1195. doi:10.1038/nm1197-1193
   PubMed Web of Science ®Google Scholar
• Barkhausen T, Tschernig T, Rosenstiel P, et al. Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model. Crit Care Med. 2011;39(6):1407–1413. doi:10.1097/CCM.0b013e318211ff56
   PubMed Web of Science ®Google Scholar
• Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014;14(3):141–153. doi:10.1038/nri3608
   PubMed Web of Science ®Google Scholar
• Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24(2):179–189. doi:10.1016/j.immuni.2006.01.001
   PubMed Web of Science ®Google Scholar
• Yao Z, Painter SL, Fanslow WC, et al. Human IL-17: a novel cytokine derived from T cells. J Immunol. 1995;155(12):5483–5486.
   PubMed Web of Science ®Google Scholar
• Erbel C, Akhavanpoor M, Okuyucu D, et al. IL-17A influences essential functions of the monocyte/macrophage lineage and is involved in advanced murine and human atherosclerosis. J Immunol. 2014;193(9):4344–4355. doi:10.4049/jimmunol.1400181
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235–238. doi:10.1038/nature04753
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531–562. doi:10.1146/annurev.immunol.21.120601.141122
   PubMed Web of Science ®Google Scholar
• Song KH, Li T, Owsley E, Strom S, Chiang JY. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Hepatology. 2009;49(1):297–305. doi:10.1002/hep.22627
   PubMed Web of Science ®Google Scholar
• Tomlinson E, Fu L, John L, et al. Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology. 2002;143(5):1741–1747. doi:10.1210/endo.143.5.8850
   PubMed Web of Science ®Google Scholar
• Chen WLK, Edington C, Suter E, et al. Integrated gut/liver microphysiological systems elucidates inflammatory inter-tissue crosstalk. Biotechnol Bioeng. 2017;114(11):2648–2659. doi:10.1002/bit.26370
   PubMed Web of Science ®Google Scholar
• Inagaki T, Moschetta A, Lee YK, et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A. 2006;103(10):3920–3925. doi:10.1073/pnas.0509592103
   PubMed Web of Science ®Google Scholar
• Wang YD, Chen WD, Wang M, Yu D, Forman BM, Huang W. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response. Hepatology. 2008;48(5):1632–1643. doi:10.1002/hep.22519
   PubMed Web of Science ®Google Scholar
• Inagaki T, Choi M, Moschetta A, et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2005;2(4):217–225. doi:10.1016/j.cmet.2005.09.001
   PubMed Web of Science ®Google Scholar
• Tomiyama K, Maeda R, Urakawa I, et al. Relevant use of Klotho in FGF19 subfamily signaling system in vivo. Proc Natl Acad Sci U S A. 2010;107(4):1666–1671. doi:10.1073/pnas.0913986107
   PubMed Web of Science ®Google Scholar
• Huang X, Yang C, Luo Y, Jin C, Wang F, McKeehan WL. FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver. Diabetes. 2007;56(10):2501–2510. doi:10.2337/db07-0648
   PubMed Web of Science ®Google Scholar
• Kir S, Beddow SA, Samuel VT, et al. FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Science. 2011;331(6024):1621–1624. doi:10.1126/science.1198363
   PubMed Web of Science ®Google Scholar
• Turner N, Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer. 2010;10(2):116–129. doi:10.1038/nrc2780
   PubMed Web of Science ®Google Scholar
• Arab JP, Karpen SJ, Dawson PA, Arrese M, Trauner M. Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Hepatology. 2017;65(1):350–362. doi:10.1002/hep.28709
   PubMed Web of Science ®Google Scholar
• Matye DJ, Wang H, Luo W, et al. Combined ASBT Inhibitor and FGF15 treatment improves therapeutic efficacy in experimental nonalcoholic steatohepatitis. Cell Mol Gastroenterol Hepatol. 2021;12(3):1001–1019. doi:10.1016/j.jcmgh.2021.04.013
   PubMed Web of Science ®Google Scholar
• Yi C, Chen L, Lin Z, et al. Lenvatinib targets FGF receptor 4 to enhance antitumor immune response of anti-programmed cell death-1 in HCC. Hepatology. 2021;74(5):2544–2560. doi:10.1002/hep.31921
   PubMed Web of Science ®Google Scholar
• Baker CC, Chaudry IH, Gaines HO, Baue AE. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery. 1983;94(2):331–335.
   PubMed Web of Science ®Google Scholar
• Klopfleisch R. Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology--a systematic review. BMC Vet Res. 2013;21(9):123. doi:10.1186/1746-6148-9-123
   Web of Science ®Google Scholar
• Gaitantzi H, Karch J, Germann L, et al. BMP-9 Modulates the Hepatic Responses to LPS. Cells. 2020;9(3):617. doi:10.3390/cells9030617
   PubMed Web of Science ®Google Scholar
• Reynolds JM, Martinez GJ, Chung Y, Dong C. Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc Natl Acad Sci. 2012;109(32):13064–13069. doi:10.1073/pnas.1120585109
   PubMed Web of Science ®Google Scholar
• Dejager L, Pinheiro I, Dejonckheere E, Libert C. Cecal ligation and puncture: the gold standard model for polymicrobial sepsis? Trends Microbiol. 2011;19(4):198–208. doi:10.1016/j.tim.2011.01.001
   PubMed Web of Science ®Google Scholar
• Yeh CL, Tanuseputero SA, Wu JM, et al. Intravenous arginine administration benefits CD4+ T-cell homeostasis and attenuates liver inflammation in mice with polymicrobial sepsis. Nutrients. 2020;12(4):1047. doi:10.3390/nu12041047
   PubMed Web of Science ®Google Scholar
• Di Caro V, Cummings JL, Alcamo AM, et al. Dietary cellulose supplementation modulates the immune response in a murine endotoxemia model. Shock. 2019;51(4):526–534. doi:10.1097/SHK.0000000000001180
   PubMed Web of Science ®Google Scholar
• Shen X, Li N, Li H, Zhang T, Wang F, Li Q. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma. J Cancer Res Clin Oncol. 2010;136(11):1745–1754. doi:10.1007/s00432-010-0833-8
   PubMed Web of Science ®Google Scholar
• Zhao J, Liu Y, Hu JN, et al. Autocrine regulation of interleukin-3 in the activity of regulatory T cells and its effectiveness in the pathophysiology of sepsis. J Infect Dis. 2021;223(5):893–904.
   PubMed Web of Science ®Google Scholar
• Tran DT, Jeong YY, Kim JM, Bae HB, Son SK, Kwak SH. The anti-inflammatory role of bilirubin on “Two-Hit” sepsis animal model. Int J Mol Sci. 2020;21(22):8650. doi:10.3390/ijms21228650
   PubMed Web of Science ®Google Scholar
• Osinalde N, Mitxelena J, Sánchez-Quiles V, et al. Nuclear phosphoproteomic screen uncovers ACLY as mediator of IL-2-induced proliferation of CD4+ T lymphocytes. Mol Cell Proteomics. 2016;15(6):2076–2092. doi:10.1074/mcp.M115.057158
   PubMed Web of Science ®Google Scholar
• Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP. Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation. 2005;12(5):255–269. doi:10.1159/000087104
   PubMed Web of Science ®Google Scholar
• Li X, Zhou T, Zhu Z, Xu B. High concentration of serum FGF19 at ICU admission is associated with 28-day mortality in sepsis patients. Clin Chim Acta. 2021;523:513–518. doi:10.1016/j.cca.2021.11.002
   PubMed Web of Science ®Google Scholar